Pediatrix Medical
About: Pediatrix Medical Group Inc provides physician services to hospitals, intensive care units, and other medical units. The services provided by the company include maternal care for expectant mothers, intensive care for premature babies, cardiology care for infants suffering from heart defects, and anesthesia care during surgeries, among others. The company operates only under one segment and generates majority of the revenue through neonatology and other pediatric subspecialties.
Employees: 2,900
0
Funds holding %
of 6,809 funds
0
Analysts bullish %
of 6 analysts
Fund manager confidence
Based on 2024 Q3 regulatory filings by fund managers ($100M+ AUM)
580% more call options, than puts
Call options by funds: $401K | Put options by funds: $59K
100% more funds holding in top 10
Funds holding in top 10: 1 [Q2] → 2 (+1) [Q3]
45% more capital invested
Capital invested by funds: $687M [Q2] → $995M (+$308M) [Q3]
3% less repeat investments, than reductions
Existing positions increased: 76 | Existing positions reduced: 78
5% less funds holding
Funds holding: 227 [Q2] → 215 (-12) [Q3]
8.15% less ownership
Funds ownership: 108.2% [Q2] → 100.05% (-8.15%) [Q3]
32% less first-time investments, than exits
New positions opened: 26 | Existing positions closed: 38
Research analyst outlook
6 Wall Street Analysts provided 1 year price targets over the past 3 months
Low target
$15
6%
upside
Avg. target
$16.42
17%
upside
High target
$18
28%
upside
6 analyst ratings
2 positive
33%
4 neutral
67%
0 negative
0%
Macquarie Tao Qiu 33% 1-year accuracy 5 / 15 met price target | 28%upside $18 | Outperform Initiated | 16 Dec 2024 |
Mizuho Ann Hynes 41% 1-year accuracy 9 / 22 met price target | 6%upside $15 | Neutral Maintained | 19 Nov 2024 |
UBS A.J. Rice 41% 1-year accuracy 7 / 17 met price target | 17%upside $16.50 | Neutral Maintained | 5 Nov 2024 |
Jefferies Jack Slevin 33% 1-year accuracy 1 / 3 met price target | 28%upside $18 | Buy Maintained | 5 Nov 2024 |
Deutsche Bank Pito Chickering 42% 1-year accuracy 5 / 12 met price target | 6%upside $15 | Hold Maintained | 4 Nov 2024 |
Financial journalist opinion
Based on 5 articles about MD published over the past 30 days
Neutral
Zacks Investment Research
1 day ago
Is Your Portfolio Missing These 5 High-Growth Healthcare Stocks?
The Healthcare sector sees volume growth and improved occupancy while battling rising medical costs and regulatory uncertainty.
Positive
Zacks Investment Research
4 days ago
Why Pediatrix Medical Group (MD) is a Top Value Stock for the Long-Term
Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.
Positive
Zacks Investment Research
1 week ago
MD or AVTR: Which Is the Better Value Stock Right Now?
Investors with an interest in Medical Services stocks have likely encountered both Pediatrix Medical Group (MD) and Avantor, Inc. (AVTR). But which of these two companies is the best option for those looking for undervalued stocks?
Positive
Zacks Investment Research
3 weeks ago
Despite Fast-paced Momentum, Pediatrix Medical Group (MD) Is Still a Bargain Stock
Pediatrix Medical Group (MD) could be a great choice for investors looking to buy stocks that have gained strong momentum recently but are still trading at reasonable prices. It is one of the several stocks that made it through our 'Fast-Paced Momentum at a Bargain' screen.
Neutral
Zacks Investment Research
3 weeks ago
MD or AVTR: Which Is the Better Value Stock Right Now?
Investors with an interest in Medical Services stocks have likely encountered both Pediatrix Medical Group (MD) and Avantor, Inc. (AVTR). But which of these two stocks offers value investors a better bang for their buck right now?
Positive
Zacks Investment Research
1 month ago
Pediatrix Medical Group (MD) Is Attractively Priced Despite Fast-paced Momentum
If you are looking for stocks that have gained strong momentum recently but are still trading at reasonable prices, Pediatrix Medical Group (MD) could be a great choice. It is one of the several stocks that passed through our 'Fast-Paced Momentum at a Bargain' screen.
Positive
Zacks Investment Research
1 month ago
Pediatrix Medical Stock Soars 30.5% Since Q3 Earnings Beat
MD expects transformational and restructuring-related expenses to be $48 million in 2024.
Positive
Zacks Investment Research
1 month ago
MD vs. AVTR: Which Stock Is the Better Value Option?
Investors looking for stocks in the Medical Services sector might want to consider either Pediatrix Medical Group (MD) or Avantor, Inc. (AVTR). But which of these two companies is the best option for those looking for undervalued stocks?
Neutral
Seeking Alpha
1 month ago
Pediatrix Medical Group, Inc. (MD) Q3 2024 Earnings Call Transcript
Pediatrix Medical Group, Inc. (NYSE:MD ) Q3 2024 Earnings Conference Call November 1, 2024 9:00 AM ET Company Participants Charles Lynch - Senior Vice President, Finance and Strategy James Swift - Chief Executive Officer Kasandra Rossi - Executive Vice President, Chief Financial Officer and Treasure Conference Call Participants Jack Senft - William Blair Jack Slevin - Jefferies A.J. Rice - UBS Operator Ladies and gentlemen, thank you for standing by and welcome to the 2024 Third Quarter's Earnings Conference.
Positive
Zacks Investment Research
1 month ago
Pediatrix Medical Group (MD) Surpasses Q3 Earnings and Revenue Estimates
Pediatrix Medical Group (MD) came out with quarterly earnings of $0.44 per share, beating the Zacks Consensus Estimate of $0.37 per share. This compares to earnings of $0.32 per share a year ago.
Charts implemented using Lightweight Charts™